Please assess the completion status of the following clinical trial:

Trial Title: Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient's who fulfilled the International Criteria for Behcet's Disease.~Exclusion Criteria:~* major organ involvement~* Hypersensitivity reaction

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Colchicine (Type: ACTIVE_COMPARATOR): Patients who received Colchicine and went on placebo after 4 months
- Placebo (Type: PLACEBO_COMPARATOR): Patients who received placebo and went on Colchicine after 4 months

Based on this trial design, predict the completion outcome and termination type (if applicable).